You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/40181
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGomes, K. S.-
dc.contributor.authorNunes-De-Souza, R. L.-
dc.date.accessioned2014-05-20T15:30:53Z-
dc.date.accessioned2016-10-25T18:06:34Z-
dc.date.available2014-05-20T15:30:53Z-
dc.date.available2016-10-25T18:06:34Z-
dc.date.issued2009-10-01-
dc.identifierhttp://dx.doi.org/10.1016/j.pnpbp.2009.07.015-
dc.identifier.citationProgress In Neuro-psychopharmacology & Biological Psychiatry. Oxford: Pergamon-Elsevier B.V. Ltd, v. 33, n. 7, p. 1261-1269, 2009.-
dc.identifier.issn0278-5846-
dc.identifier.urihttp://hdl.handle.net/11449/40181-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/40181-
dc.description.abstractA single exposure to the elevated plus-maze test (EPM) increases open arms avoidance and reduces or abolishes the anxiolytic-like effect of benzodiazepines assessed during a second trial, a phenomenon defined as "one-trial tolerance" (OTT). It has been emphasized that the dorsal portion of the midbrain periaqueductal gray (dPAG) plays a role on this enhanced aversion phenomenon in maze-experienced rodents. Given that intra-dPAG injections of a wide range of serotonergic 5-HT(1A), 5-HT(2A) and 5-HT(2C) receptor agonists produce anxiolytic-like effects in maze-naive rodents, the present study examined the effects of the 5-HT(1A) receptor agonist 8-OH-DPAT (5.6 and 10.0 nmol in 0.15 mu l) the preferential 5-HT(2A) receptor agonist DOI (2.0 and 8.0 nmol in 0.1 mu l) and the preferential 5-HT(2C) receptor agonist MK-212 (21.2 and 63.6 nmol in 0.1 mu l) microinjected into the dPAG prior to Trial 1 and Trial 2 on the behaviour of mice in the EPM. Test sessions were recorded and subsequently scored for anxiety-like behaviour (percentage of open arms entries and time) as well as general locomotor activity (closed arm entries). The results showed a lack of 8-OH-DPAT (5.6 and 10.0 nmol) effect on the behaviour of maze-naive and maze-experienced mice, while intra-dPAG microinfusions of DOI (8 nmol) reduced anxiety-like behaviour only in maze-experienced mice that had received a similar treatment prior to Trial 1. Furthermore, intra-dPAG MK-212 (63.6 nmol) showed an anxiolytic-like effect on both Trial I and Trial 2. Importantly, these effects were observed in the absence of any significant change in closed arm entries, the parameter considered to be a valid index of locomotor activity in the plus-maze. These results support the dPAG as a crucial structure involved in the neurobiology of the OTT phenomenon as well as accounting the role of the 5-HT(2A) and 5-HT(2C) receptors located within this midbrain structure on the emotional state induced by EPM test and retest paradigm mice. (C) 2009 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipPrograma de Apoio ao Desenvolvimento Científico da Faculdade de Ciências Farmacêuticas da UNESP (PADC)-
dc.format.extent1261-1269-
dc.language.isoeng-
dc.publisherPergamon-Elsevier B.V. Ltd-
dc.sourceWeb of Science-
dc.subject5-HT(1A) and 5-HT(2A/2C) receptorsen
dc.subjectElevated plus-mazeen
dc.subjectMiceen
dc.subjectOne-trial toleranceen
dc.subjectPeriaqueductal grayen
dc.titleImplication of the 5-HT(2A) and 5-HT(2C) (but not 5HT(1A)) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in miceen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationUNESP, Lab Neuropsicofarmacol, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUSP, Programa Posgrad Psicobiol, BR-14040901 Ribeirao Preto, SP, Brazil-
dc.description.affiliationUSP, Inst Neurociencias & Comportamento INeC, BR-14040901 Ribeirao Preto, SP, Brazil-
dc.description.affiliationUnespUNESP, Lab Neuropsicofarmacol, BR-14801902 Araraquara, SP, Brazil-
dc.description.sponsorshipIdFAPESP: 02/03705-0-
dc.description.sponsorshipIdFAPESP: 04/14490-0-
dc.description.sponsorshipIdCNPq: 309407/2006-0-
dc.identifier.doi10.1016/j.pnpbp.2009.07.015-
dc.identifier.wosWOS:000270285500028-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofProgress In Neuro-psychopharmacology & Biological Psychiatry-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.